PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsrotavirus infections
MeSH D012400 - rotavirus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012088:Reoviridae infections
0 Companies
0 Drugs
Success rate
D012400: 
Rotavirus infections
3 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
1/1
Phase 3
0%
0/3
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Antithrombin iii,
Ademetionine,
Bevifimod,
Synflorix,
Fendrix,
Prevenar13,
Prevnar13,
Pneumovax,
Ipv,
Pcv,
Prevenar
Merck & Co
Antithrombin iii,
Ademetionine,
Mmc,
Ipv
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use